Atossa Therapeutics Inc (NASDAQ:ATOS)

0.8357
Delayed Data
As of 3:50pm ET
 +0.0057 / +0.69%
Today’s Change
0.50
Today|||52-Week Range
1.62
+58.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-15.8M-6.4M-8.1M-11.4M
 
 
 
 
 
Depreciation272.6K303.5K129.0K44.2K
 
 
 
 
 
Total Other Cash Flow1.2M1.8M1.7M2.5M
 
 
 
 
 
Funds From Operations-14.3M-4.3M-6.3M-8.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-601.1K1.3M339.9K64.4K
 
 
 
 
 
Net Cash Flow - Operating Activities-13.7M-5.6M-6.6M-9.0M
 
 
 
 
 
 
InvestingCapital Expenditures-130.7K-9.2K0.00-110.9K
 
 
 
 
Other Investing - Uses-157.7K0.000.000.00
 
 
Net Cash Flow Investing-288.4K-9.2K0.00-110.9K
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale9.5M4.7M10.8M12.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.00--0.000.00--
Cash Dividends Paid - Total0.00--0.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing9.5M4.7M10.8M12.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-4.5M-907.9K4.2M3.2M